Literature DB >> 877185

Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms.

E C Johnstone, T J Crow, K Mashiter.   

Abstract

Prolactin, FSH, LH and TSH were determined in repeated samples of serum from 16 unmedicated male patients with chronic schizophrenia. Changes in the mental states between the 2 occasions were related to changes in hormone levels. Significant inverse correlations were established between prolactin and incoherence of speech, between prolactin and total positive symptoms and between FSH and poverty of speech. A significant positive correlation was established between FSH and delusions. These findings are discussed in the context of evidence concerning the role of monoamines in the control of anterior pituitary function, and of the dopamine and other monoamine hypotheses of schizophrenia. Although prolactin secretion was not as low, as would be predicted on the basis of the dopamine overactivity hypothesis of schizophrenia, the relationship between symptom change and change in prolactin secretion was consistent with the hypothesis that increasing symptom severity is associated with increasing dopamine release from the tubero-infundibular system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 877185     DOI: 10.1017/s0033291700029299

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

1.  The role of dopamine in the antipsychotic effect and the pathogenesis of schizophrenia.

Authors:  T J Crow; E C Johnstone; A Longden; F Owen; G Riley
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

Authors:  J D Wilson; D J King; B Sheridan
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

4.  Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model.

Authors:  M H Joseph; C D Frith; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

5.  Concentrations of homovanillic Acid and gonadal hormones in the serum of male schizophrenic patients.

Authors:  S L Gong; J Wei; C N Ramchand; R Ramchand; G P Hemmings
Journal:  Indian J Psychiatry       Date:  1993-07       Impact factor: 1.759

Review 6.  The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness.

Authors:  R Miller
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients.

Authors:  M L Rao; G Gross; G Huber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

8.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 9.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.